Employment
-
King Edward Memorial Hospital Research Centre Consultant Pediatric research2010 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (15)
- Long-term impact of a reduced two-dose (1p+1) schedule of 10- and 13-valent pneumococcal conjugate vaccines (Synflorix and Prevenar13)) on nasopharyngeal carriage in rural Indian children: A prospective cohort study Save
- Immunogenicity of Neonatal versus Infant Schedules of Rotavirus Vaccines in India: Study Protocol for a Phase IV Randomized Controlled Trial Save
- Immunogenicity of Neonatal versus Infant Schedules of Rotavirus Vaccines in India: Study Protocol for a Phase IV Randomized Controlled Trial [version 1] Save
- Immunogenicity and safety of Biological E's 14-valent pneumococcal conjugate vaccine (PNEUBEVAX 14®) administered in a 2p + 1 schedule to healthy infants: a multicenter, randomized, active controlled, single-blind, phase III trial Save
- The ProSPoNS Trial: Statistical Analysis Protocol for Evaluating Efficacy of Probiotic Supplementation for Prevention of Neonatal Sepsis in 0–2-month-old Low Birth Weight Infants in India Save
- Long-term impact of a reduced two-dose (1p+1) schedule of 10- and 13-valent pneumococcal conjugate vaccines (Synflorix and Prevenar13)) on nasopharyngeal carriage in rural Indian children: A prospective cohort study [version 2; peer review: 1 approved wi… Save
- Long-term impact of a reduced two-dose (1p+1) schedule of 10- and 13-valent pneumococcal conjugate vaccines (Synflorix and Prevenar13)) on nasopharyngeal carriage in rural Indian children: A prospective cohort study Save
- Knowledge, attitudes, awareness and factors associated with the uptake of influenza vaccine among pregnant women in urban Pune Save
- Safety and Protective Effects of Influenza Vaccination in Pregnant Women on Pregnancy and Birth Outcomes in Pune, India: A Cross-Sectional Study Save
- Effect of reduced two-dose (1+1) schedule of 10 and 13-valent pneumococcal conjugate vaccines (SynflorixTM and Prevenar13TM)) on nasopharyngeal carriage and serotype-specific immune response in the first two years of life: Results from an open-labelled r… Save